Mustafa Sahbazlar

11PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersEnvironmental studies in animal productionCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 11, 2026
Prognostic value of the CHAM score in non-small cell lung cancer patients treated with nivolumab.

|May 27, 2026
A PET-Derived SUVmax-to-Albumin Ratio Predicts Recurrence After Neoadjuvant FLOT in Gastric Cancer.

|Mar 28, 2026
Modified Aarhus Composite Biomarker Score as a New Risk-Stratification Tool in Metastatic Colorectal Cancer.

Nagihan Kolkıran, Atike Pınar Erdoğan, Mustafa Şahbazlar

|Feb 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal, Hasan Cagri Yildirim, Deniz Can Guven

|Feb 27, 2026
Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study.

Omer Acar, Çağdaş Rıza Açar, İhsan Sebnem Orguc

|Jan 12, 2026
Nephrotoxicity secondary to CDK 4/6 inhibitors in advanced breast cancer patients and its impact on survival.

Tugay Avci, Ahmet Anil Altunbas, Mustafa Sahbazlar

Pageof 2

Frequent Collaborators

8 joint publications

Ferhat Ekinci

8 joint publications

Atike Pınar Erdogan

2 joint publications

Tugay Avci

2 joint publications

Ahmet Burak Agaoglu